understanding stock market

Has it really been half a century since “Love Me Do”? (Photo by Kevin Winter/Getty Images)

Paul McCartney’s lawsuit against Sony/ATV to regain control of the songs he wrote with John Lennon in the 1960s has a lot to do with how Duran Duran lost its fight for its songs from the ’80s.

The Beatle sued the Sony music unit after receiving a series of threats from Sony/ATV chief Martin Bandier and others that a U.K. court decision holding Duran Duran liable for trying to terminate its license agreements under U.S. law could cause trouble for McCartney in his own efforts.

Bandier ran into McCartney’s lawyer Lee Eastman after Duran Duran lost its case in December and said McCartney would “need to discuss how to handle his copyrights” in view of the decision, McCartney says in his suit filed in federal court in New York.

understanding stock market: Energy XXI Ltd. (EXXIQ)

Advisors’ Opinion:


    The reality is often different. What is going on with Bellatrix Exploration is actually above average. I have written about many companies such as Sandridge Energy (NYSE:SD), Energy XXI (OTCPK:EXXIQ), and Halcon Resources (NYSE:HK) where the companies supposedly has premier assets, fantastically valuable reserves, and the investors lost everything. Right now Chesapeake Energy (NYSE:CHK) appears to be heading down the same miserable pathway as the others. At least with Bellatrix, the company appears to be entering the slow turnaround phase. But this has definitely not been a painless experience.

understanding stock market: Extra Space Storage Inc(EXR)

Advisors’ Opinion:

  • [By Matthew Frankel]

    The final REIT type I like right now is self-storage, particularly Extra Space Storage (NYSE:EXR).

    First, I should mention that this could prove to be the most volatile company on the list. Self-storage isn’t as defensive as retail or healthcare simply because of its lease structure. Generally, you don’t sign a multi-year lease on a storage unit — you just pay each month that you want to keep it. This makes it easier for tenants to vacate the properties during tough times.

understanding stock market: Nucor Corporation(NUE)

Advisors’ Opinion:

  • [By Ben Levisohn]

    But U.S. Steel is getting killed, as are AK Steel (AKS), Steel Dynamics (STLD) and Nucor (NUE). Can we chalk it up to Paul Ryan’s comments that tax reform could take longer than health care reform, which also seems to be tanking the overall market?

  • [By Merrick Weingarten]

    Steel stocks were up big on Tuesday ahead of the Department of Commerce hearing on the Section 232 probe. The DoC is set to come out with more details regarding the impact steel imports has on U.S. national security.

    Stock Movements
    United States Steel Corporation (NYSE: X): Up 5.27 percent. AK Steel Holding Corporation (NYSE: AKS): Up 9.55 percent. Nucor Corporation (NYSE: NUE): Up 3.54 percent. Steel Dynamics, Inc. (NASDAQ: STLD): Up 4.08 percent. Worthington Industries, Inc. (NYSE: WOR): Up 3.29 percent.
    Analyst Commentary

    A Jefferies research analyst suggested a high probability of the DoC institutes more incremental trade defense measures but noted most of the investigation remains unknown going into Wednesday.

  • [By Jon C. Ogg]

    Then there are the steel plays. United States Steel Corp. (NYSE: X) was up 7.4% at $27.61 late on Monday. It has a market cap of $4.5 billion. Over the past five trading days the stock has gained 30%. Nucor Corp. (NYSE: NUE) was last seen up 1% at $59.34. Nucor has a total market cap of $18.8 billion. Over the past fivetrading days the stock has gained 17%.

  • [By Ben Levisohn]

    There’s been a lot of talk that the revival of the Keystone XL pipeline–and the possibility of other pipelines as well–could boost the shares of steel makers like U.S. Steel (X), AK Steel (AKS), Nucor (NUE) and Steel Dynamics (STLD). Axiom Capital’s Gordon Johnson disagrees:

understanding stock market: NxStage Medical, Inc.(NXTM)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, healthcare shares dipped by 0.51 percent. Meanwhile, top losers in the sector included NxStage Medical, Inc. (NASDAQ: NXTM), down 8 percent, and Valeant Pharmaceuticals Intl Inc (NYSE: VRX), down 9 percent.

Leave a Reply

Your email address will not be published.